Last edition
News about "WuXi Biologics"
WuXi Biologics, a leading global contract research, development and manufacturing organisation (CRDMO), has announced that its Dundalk, Ireland facility has been approved by the European Medicines Agency (EMA) as a commercial manufacturing site for a client’s innovative biologic.
WuXi Biologics | 18/08/2025 | By Dineshwori | 140
WuXi Biologics Completes First Commercial PPQ Campaign at MFG20 Hangzhou Facility
WuXi Biologics completes the first commercial project Process Performance Qualification (PPQ) campaign for its three sets of 5,000L single-use bioreactors (SUBs).
WuXi Biologics | 19/04/2025 | By Abha | 154
WuXi Biologics Signs Deal with Candid Therapeutics to Boost Trispecific T-cell Engager
Under the terms of the agreement, Candid will have exclusive global rights to a preclinical trispecific T-cell Engager discovered at WuXi Biologics' proprietary universal multispecific antibody platform WuXiBody.
WuXi Biologics | 07/01/2025 | By Aishwarya | 224
WuXi Biologics, Boostimmune Ink MOU for Exclusive R&D Services
WuXi Biologics, Boostimmune Ink MOU for Exclusive R&D Services<br />
WuXi Biologics | 24/08/2023 | By Sudeep Soparkar | 649
Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership
Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership
WuXi Biologics | 28/06/2023 | By Sudeep Soparkar | 767
WuXi Biologics' drug substance and drug product facilities bags US FDA, EMA approval
These approvals add to the previous 25 certifications from more than 10 global regulatory administrations
WuXi Biologics | 20/09/2022 | By Sudeep Soparkar | 713
The facility has been successfully performing CMC projects for multiple clients since early 2022
WuXi Biologics | 20/07/2022 | By Sudeep Soparkar | 664
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy